Essex Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Sell
6,864
-115
-2% -$41K 0.14% 153
2025
Q4
$2.28M Buy
6,979
+1,415
+25% +$449K 0.13% 157
2025
Q3
$1.57M Sell
5,564
-653
-11% -$189K 0.09% 191
2025
Q2
$1.74M Buy
6,217
+1,110
+22% +$314K 0.11% 168
2025
Q1
$1.59M Sell
5,107
-92
-2% -$27.2K 0.11% 166
2024
Q4
$1.36M Buy
5,199
+321
+7% +$95.2K 0.1% 185
2024
Q3
$1.56M Sell
4,878
-1,862
-28% -$609K 0.11% 171
2024
Q2
$2.19M Buy
6,740
+748
+12% +$220K 0.16% 123
2024
Q1
$1.7M Sell
5,992
-101
-2% -$29.6K 0.16% 134
2023
Q4
$1.76M Sell
6,093
-163
-3% -$44.4K 0.18% 116
2023
Q3
$1.68M Sell
6,256
-78
-1% -$19.5K 0.19% 111
2023
Q2
$1.41M Sell
6,334
-327
-5% -$75.9K 0.16% 130
2023
Q1
$1.61M Buy
6,661
+330
+5% +$81K 0.17% 126
2022
Q4
$1.66M Sell
6,331
-37
-0.6% -$9.92K 0.18% 118
2022
Q3
$1.44M Sell
6,368
-45
-0.7% -$10.9K 0.17% 123
2022
Q2
$1.56M Sell
6,413
-205
-3% -$50.2K 0.17% 120
2022
Q1
$1.6M Sell
6,618
-91
-1% -$20.9K 0.15% 136
2021
Q4
$1.51M Sell
6,709
-591
-8% -$125K 0.15% 149
2021
Q3
$1.55M Buy
7,300
+4,284
+142% +$986K 0.18% 131
2021
Q2
$750K Hold
3,016
0.11% 191
2021
Q1
$750K Sell
3,016
-2,046
-40% -$488K 0.13% 160
2020
Q4
$1.16M Buy
5,062
+103
+2% +$23.7K 0.23% 106
2020
Q3
$1.26M Buy
4,959
+115
+2% +$28.5K 0.31% 76
2020
Q2
$1.14M Sell
4,844
-30
-0.6% -$6.84K 0.35% 75
2020
Q1
$988K Sell
4,874
-5,106
-51% -$1.12M 0.35% 74
2019
Q4
$2.41M Buy
9,980
+59
+0.6% +$13K 0.66% 43
2019
Q3
$1.92M Sell
9,921
-40,328
-80% -$7.74M 0.62% 47
2019
Q2
$9.26M Buy
50,249
+550
+1% +$98.5K 2.73% 5
2019
Q1
$9.44M Sell
49,699
-514
-1% -$98.2K 2.85% 5
2018
Q4
$9.78M Sell
50,213
-785
-2% -$153K 2.99% 5
2018
Q3
$10.6M Buy
50,998
+3,483
+7% +$686K 2.33% 6
2018
Q2
$8.77M Buy
47,515
+619
+1% +$109K 2.11% 8
2018
Q1
$8M Sell
46,896
-5,450
-10% -$1M 1.57% 9
2017
Q4
$9.1M Sell
52,346
-150
-0.3% -$26.5K 2.16% 8
2017
Q3
$9.79M Sell
52,496
-204
-0.4% -$36.1K 2.4% 7
2017
Q2
$9.08M Sell
52,700
-552
-1% -$89.8K 1.91% 7
2017
Q1
$8.74M Sell
53,252
-945
-2% -$157K 2.01% 6
2016
Q4
$7.92M Buy
54,197
+543
+1% +$81.7K 1.7% 9
2016
Q3
$8.94M Buy
53,654
+630
+1% +$107K 2.13% 6
2016
Q2
$8.07M Sell
53,024
-88
-0.2% -$13.7K 1.95% 7
2016
Q1
$7.96M Sell
53,112
-50
-0.1% -$7.43K 1.97% 7
2015
Q4
$8.63M Buy
53,162
+125
+0.2% +$19.6K 2.07% 6
2015
Q3
$7.34M Buy
53,037
+29,850
+129% +$4.71M 1.91% 7
2015
Q2
$3.56M Sell
23,187
-125
-0.5% -$20K 0.92% 24
2015
Q1
$3.73M Buy
23,312
+100
+0.4% +$15.7K 0.96% 20
2014
Q4
$3.7M Buy
23,212
+15,185
+189% +$2.37M 0.96% 21
2014
Q3
$1.13M Buy
8,027
+1,385
+21% +$181K 0.34% 74
2014
Q2
$786K Sell
6,642
-440
-6% -$50.9K 0.24% 107
2014
Q1
$873K Buy
7,082
+645
+10% +$78.2K 0.29% 85
2013
Q4
$734K Buy
6,437
+2,155
+50% +$245K 0.25% 100
2013
Q3
$479 Sell
4,282
-228
-5% -$24.7K 0.15% 135
2013
Q2
$445K Buy
+4,510
New +$468K 0.16% 141

Other funds holding AMGN

Essex Financial Services's AMGN Position: Q1 2026 in Review

Essex Financial Services reduced its Amgen (AMGN) stake by 1.6% in Q1 2026, selling an estimated $41K and leaving 6,864 shares worth $2.42M. The position accounts for 0.14% of the portfolio, ranked #153.

Essex Financial Services first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.6M in Q3 2018. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Essex Financial Services held 6,864 shares of Amgen worth $2.42M as of Q1 2026.
  • Essex Financial Services sold 115 Amgen shares in Q1 2026, an estimated $41K.
  • Amgen made up 0.14% of Essex Financial Services's portfolio in Q1 2026, its #153 holding.
  • Essex Financial Services first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Essex Financial Services's Amgen position peaked at $10.6M in Q3 2018.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.